Point-of-Care Glucose Testing Market: Growth and Innovation Fueling the Future of Diabetes Management

Point-of-Care Glucose Testing Market: Growth and Innovation Fueling the Future of Diabetes Management

According to Next Move Strategy Consulting, the global Point-of-Care (POC) Glucose Testing Market is poised for substantial growth, expected to reach USD 4 billion by 2030, with a CAGR of 4% from 2024 to 2030. The market encompasses portable testing equipment used to monitor blood glucose levels, offering healthcare professionals and patients immediate results for the effective management of diabetes.

Download Free Sample: https://www.nextmsc.com/point-of-care-glucose-testing-market/request-sample

Market Dynamics and Trends

The surge in diabetes prevalence, largely driven by sedentary lifestyles and unhealthy eating habits, is significantly boosting demand for point-of-care glucose testing. Non-invasive glucose monitoring is crucial for managing diabetes, and advancements in technology are making these devices increasingly accurate and user-friendly.

In 2021, 529 million people worldwide were diagnosed with diabetes, a figure expected to rise to 1.3 billion by 2050. As a result, the demand for real-time, reliable blood glucose monitoring devices continues to grow. For example, Roche’s launch of the cobas pulse in 2022 integrated innovative software to improve glucose management, enhancing user-friendliness in clinical settings.

The increasing global aging population is another factor contributing to market growth, as older individuals are more susceptible to diabetes and related complications. In 2023, more than 20% of individuals aged 65 and older globally were affected by diabetes, highlighting the need for convenient monitoring devices to manage glucose levels effectively.

Technological Innovations and Opportunities

Technological advancements in the point-of-care glucose testing market are revolutionizing diabetes care. The integration of biosensors and wearable technologies into glucose monitoring systems is improving accuracy and usability. For instance, Abbott’s next-generation biosensing devices, introduced in 2022, offer continuous glucose monitoring and real-time data, making it easier for patients to manage their condition seamlessly throughout the day.

Regional Growth Insights

North America dominates the point-of-care glucose testing market due to favorable regulatory environments and approvals from agencies such as the FDA, which ensures the safety and effectiveness of these devices. In July 2023, Dexcom’s continuous glucose monitoring system, the Dexcom G7, received approval from Health Canada, significantly enhancing diabetes management in the region.

The Asia-Pacific region, particularly China, is also witnessing significant growth, driven by the increasing diabetes prevalence and the aging population. In 2022, China had over 141 million people with diabetes, representing one-fourth of the global diabetic population. This growing demand for accessible glucose testing devices is expected to drive market expansion in the region.

Inquire Before Buying: https://www.nextmsc.com/point-of-care-glucose-testing-market/inquire-before-buying

Competitive Landscape

Key players in the point-of-care glucose testing market include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Dexcom Inc., EKF Diagnostics Holdings plc, and Nipro Corporation, among others. These companies are actively pursuing strategic initiatives such as product innovations and acquisitions to stay competitive in the market. For example, EKF Diagnostics launched EKF Link, a digital connectivity solution, in June 2022, enabling real-time data management and improving patient care.

Conclusion

The point-of-care glucose testing market is set for continued growth, driven by rising diabetes prevalence, technological innovations, and the increasing demand for convenient, at-home glucose monitoring solutions. With advancements in biosensor technology and wearable devices, the market is expected to transform how diabetes is managed globally. As both developed and emerging economies seek to improve healthcare delivery, the future of the point-of-care glucose testing market looks promising.

Also, Browse Related Reports:   

For more information, please contact:

Next Move Strategy Consulting

E-Mail: info@nextmsc.com

Direct: +1-217-650-7991

Website: www.nextmsc.com

Follow Us: LinkedIn | Twitter | Facebook | Instagram | YouTube

About Next Move Strategy Consulting: 

Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicates as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

Back to blog